Functional assays confirmed that these compounds effectively suppressed the catalytic activity of recombinant NSUN2 without affecting NSUN6, and stereoselectively disrupted the interaction between NSUN2 and tRNA in cancer cells, leading to a global reduction of tRNA m5C levels (89). This evidence concerns the gene NSUN2 and cancer.